Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (Q44774860)
Jump to navigation
Jump to search
scientific article published on 23 February 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). |
scientific article published on 23 February 2004 |
Statements
1 reference
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (English)
1 reference
J Atzpodien
1 reference
H Kirchner
1 reference
U Jonas
1 reference
L Bergmann
1 reference
H Schott
1 reference
H Heynemann
1 reference
P Fornara
1 reference
S A Loening
1 reference
J Roigas
1 reference
S C Müller
1 reference
H Bodenstein
1 reference
S Pomer
1 reference
B Metzner
1 reference
U Rebmann
1 reference
R Oberneder
1 reference
M Siebels
1 reference
T Wandert
1 reference
T Puchberger
1 reference
M Reitz
1 reference
Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
1 reference
23 February 2004
1 reference
1 reference
Identifiers
1 reference